[continued from previous message]

12. Davous P., Fallet-Bianco C. [Familial subcortical dementia with arteriopathic leukoencephalopathy. Aclinico-pathological case]. Rev Neurol (Paris). 1991;147:376–384. [PubMed]
13. Pullicino P., Ostow P., Miller L., Snyder W., Muschauer F. Pontine ischemic rarefaction. Ann Neurol. 1995;37:460–466. [PubMed]
14. Okeda R., Arima K., Kawai M. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral
medullary arteries by reconstruction of serial sections of an autopsy case. Stroke. 2002;33:2565–2569. [PubMed]
15. Miao Q., Paloneva T., Tuominen S., et al. Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain
Pathol. 2004;14:358–364. [PubMed]
16. Zhang WW., Ma KC., Andersen O., Sourander P., Tollesson PO., Olsson Y. The microvascular changes in cases of hereditary multi-infarct disease of the brain. Acta Neuropathol (Berl). 1994;87:317–324. [PubMed]
17. Gray F., Robert F., Labrecque R., et al. Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol. 1994;20:22–30. [PubMed]
18. Mikol J., Henin D., Baudrimont M., et al. [Atypical CADASIL phenotypes and pathological findings in two new French families]. Rev Neurol (Paris). 2001;157:655–667. [PubMed]
19. Bergmann M., Ebke M., Yuan Y., Bruck W., Mugler M., Schwendemann G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): a morphological study of a German family. Acta Neuropathol (Berl). 1996;92:341–
350. [PubMed]
20. Desmond DW., Moroney JT., Lynch T., et al. CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology. 1998;51:844–849. [PubMed]
21. Filley CM., Thompson LL., Sze CI., Simon JA., Paskavitz JF., Kleinschmidt-DeMasters BK. White matter dementia in CADASIL. J Neurol Sci. 1999;163:163–167. [PubMed]
22. Gutierrez-Molina M., Caminero Rodriguez A., Martinez Garcia C., Arpa Gutierrez J., Morales Bastos C., Amer G. Small arterial granular degeneration in familial Binswanger's syndrome. Acta Neuropathol (Berl). 1994;87:98–105. [PubMed]
23. Joutel A., Andreux F., Gaulïs S., et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin invest. 2000;105:597–605. [PMC free article] [PubMed]
24. Villa N., Walker L., Lïndsell CE., Gasson J., Iruela-Arispe ML., Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev. 2001;108:161–164. [PubMed]
25. Joutel A., Corpechot C., Ducros A., et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann N Y Acad Sci. 1997;
826:213–217. [PubMed]
26. Joutel A., Tournier-Lasserve E. Notch signalling pathway and human diseases. Semin Cell Dev Biol. 1998;9:619–625. [PubMed]
27. Gray GE., Mann RS., Mïtsiadïs E., et al. Human ligands of the Notch receptor. Am J Pathol. 1999;154:785–94. [PMC free article] [PubMed]
28. Domenga V., Fardoux P., Lacombe P., et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004;18:2730–2735. [PMC free article] [PubMed]
29. Joutel A., Chabriat H., Vahedi K., et al. Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology. 2000;54:1874–1875. [PubMed]
30. Joutel A., Vahedi K., Corpechot C., et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–1515. [PubMed]
31. Dotti MT., Federico A., Mazzei R., et al. The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry. 2005;76:736–738. [PMC free article] [PubMed]
32. Peters N., Opherk C., Bergmann T., Castro M., Herzog J., Dichgans M. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol. 2005;62:1091–1094. [PubMed]
33. Blaumueller CM., Qi H., Zagouras P., Artavanis-Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90:281–291. [PubMed]
34. Joutel A., Francois A., Chabriat H., et al. [CADASIL: genetics and physiopathology]. Bull Acad Natl Med. 2000;184:1535–1542; discussion 1542-1544. [PubMed]
35. Joutel A., Tournier-Lasserve E. [Molecular basis and physiopathogenic mechanisms of CADASIL: a model of small vessel diseases of the brain]. J Soc Biol. 2002;196:109–115. [PubMed]
36. Robinson W., Galetta SL., McCluskey L., Forman MS., Balcer LJ. Retinal findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil). Surv Ophthalmol. 2001;45:445–448. [PubMed]
37. Brulin-Fardoux P., Godfrain C., Maurage CA., et al. Glycohistochemical characterization of vascular muscle cell destruction in CADASIL subjects by lectins, neoglycoconjugates and galectin-spedfic antibodies. Neuropathol Appl Neurobioi. 2003;29:400–
410. [PubMed]
38. Schroder JM., Sellhaus B., Jorg J. Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol (
Berl). 1995;89:116–121. [PubMed]
39. Goebel HH., Meyermann R., Rosin R., Schlote W. Characteristic morphologic manifestation of CADASIL, cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, in skeletal muscle and skin. Muscle Nerve. 1997;20:625–
627. [PubMed]
40. Ruchoux MM., Chabriat H., Bousser MG., Baudrimont M., TournierLasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke. 1994;25:2291–2292. [PubMed]
41. Chabriat H., Joutel A., Vahedi K., Iba-Zizen MT., Tournier-Lasserve E., Bousser MG. [CADASIL. cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalophathy]. Rev Neurol (Paris). 1997;153(67):376–385. [PubMed]
42. Ebke M., Dichgans M., Bergmann M., et al. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand. 1997;95:351–357. [PubMed]
43. Jen J., Cohen AH., Yue Q., et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology. 1997;49:1322–1330. [PubMed]
44. Schultz A., Santoïannï R., Hewan-Lowe K. Vasculopathïc changes of CADASIL can be focal in skin biopsies. Ultrastruct Pathol. 1999;23:241–247. [PubMed]
45. Joutel A., Favrole P., Labauge P., et al. Skin biopsy ïmmunostaïnïng with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet. 2001;358:2049–2051. [PubMed]
46. Ruchoux MM., Domenga V., Brulïn P., et al. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol. 2003;162:329â€
“342. [PMC free article] [PubMed]
47. Lacombe P., Oligo C., Domenga V., Tournier-Lasserve E., Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke. 2005;36:
1053–1058. [PubMed]
48. Dubroca C., Lacombe P., Domenga V., et al. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke. 2005;36:113–117. [PMC free article] [PubMed]
49. Desmond DW., Moroney JT., Lynch T., Chan S., Chin SS., Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999;30:1230–1233. [PubMed]
50. Trojano ...

*****

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)